{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T20:07:34Z","timestamp":1780085254548,"version":"3.54.0"},"reference-count":160,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T00:00:00Z","timestamp":1776211200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>Heart failure (HF) management remains challenging because patients often show large differences in how well treatments work and in how often adverse drug reactions occur. Traditional pharmacogenomics cannot fully explain these differences. Emerging evidence from pharmacomicrobiomics shows that the gut microbiome represents a previously underappreciated factor influencing drug responses. This review summarizes the two-way interactions between the gut microbiota and key HF drugs, including digoxin, angiotensin receptor-neprilysin inhibitors (ARNIs), ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), \u03b2-blockers, sodium-glucose cotransporter 2 (SGLT2) inhibitors, mineralocorticoid receptor antagonists (MRAs), and diuretics. On the one hand, gut microbes can change drug effects because they can metabolize drugs and affect host physiological pathways. On the other hand, HF drugs can change the structure and function of the gut microbial community. This review also discusses how microbiome-related features may serve as biomarkers to support personalized treatment and how strategies such as dietary changes and microbiota-targeted therapies may improve clinical outcomes. Although evidence remains limited, and certain methods require further refinement, integrating microbiome insights into HF treatment may support more precise and individualized treatment strategies and help address current therapeutic limitations.<\/jats:p>","DOI":"10.3389\/fphar.2026.1781470","type":"journal-article","created":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T05:42:29Z","timestamp":1776231749000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Harnessing the gut microbiome for precision therapeutics in heart failure"],"prefix":"10.3389","volume":"17","author":[{"given":"Jiayue","family":"Li","sequence":"first","affiliation":[{"name":"Department of Critical Care Medicine, Longhua Hospital, Shanghai University of Traditional Chinese Medicine","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaoheng","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, Longhua Hospital, Shanghai University of Traditional Chinese Medicine","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuliang","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, Longhua Hospital, Shanghai University of Traditional Chinese Medicine","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinlei","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, Longhua Hospital, Shanghai University of Traditional Chinese Medicine","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yantong","family":"Zhuge","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, Longhua Hospital, Shanghai University of Traditional Chinese Medicine","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qidong","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, Longhua Hospital, Shanghai University of Traditional Chinese Medicine","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yilin","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, Longhua Hospital, Shanghai University of Traditional Chinese Medicine","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Gao","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, Longhua Hospital, Shanghai University of Traditional Chinese Medicine","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ran","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, Longhua Hospital, Shanghai University of Traditional Chinese Medicine","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiru","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, Longhua Hospital, Shanghai University of Traditional Chinese Medicine","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qipeng","family":"Jin","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, Longhua Hospital, Shanghai University of Traditional Chinese Medicine","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiyi","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, Longhua Hospital, Shanghai University of Traditional Chinese Medicine","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,4,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2426614","DOI":"10.1080\/19490976.2024.2426614","article-title":"Mechanisms of gut bacterial metabolism of dietary polyphenols into bioactive compounds","volume":"16","author":"Alqudah","year":"2024","journal-title":"Gut Microbes"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1016\/j.amjmed.2019.04.022","article-title":"Digoxin use and associated adverse events among older adults","volume":"132","author":"Angraal","year":"2019","journal-title":"Am. J. Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s10787-024-01593-x","article-title":"Gut microbiome and inflammation in cardiovascular drug response: trends in therapeutic success and commercial focus","volume":"33","author":"Anwar","year":"2025","journal-title":"Inflammopharmacology"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1056\/NEJMoa1915928","article-title":"Vericiguat in patients with heart failure and reduced ejection fraction","volume":"382","author":"Armstrong","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"B5","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/s41591-020-01183-8","article-title":"Microbiome connections with host metabolism and habitual diet from 1,098 deeply phenotyped individuals","volume":"27","author":"Asnicar","year":"2021","journal-title":"Nat. Med."},{"key":"B6","doi-asserted-by":"publisher","first-page":"2407047","DOI":"10.1080\/19490976.2024.2407047","article-title":"Dietary fiber intake impacts gut bacterial and viral populations in a hypertensive mouse model","volume":"16","author":"Avellaneda-Franco","year":"2024","journal-title":"Gut Microbes"},{"key":"B7","doi-asserted-by":"publisher","first-page":"110296","DOI":"10.1016\/j.intimp.2023.110296","article-title":"Aspirin ameliorates atherosclerotic immuno-inflammation through regulating the treg\/Th17 axis and CD39-CD73 adenosine signaling via remodeling the gut microbiota in ApoE-\/- mice","volume":"120","author":"Bai","year":"2023","journal-title":"Int. Immunopharmacol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1161\/CIRCULATIONAHA.118.036652","article-title":"Short-chain fatty acid propionate protects from hypertensive cardiovascular damage","volume":"139","author":"Bartolomaeus","year":"2019","journal-title":"Circulation"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.3390\/antiox11091700","article-title":"Polyphenols-gut-heart: an impactful relationship to improve cardiovascular diseases","volume":"11","author":"Bianchi","year":"2022","journal-title":"Antioxidants Basel, Switz."},{"key":"B10","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1161\/CIRCULATIONAHA.123.065517","article-title":"Metabolic communication by SGLT2 inhibition","volume":"149","author":"Billing","year":"2024","journal-title":"Circulation"},{"key":"B11","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s40246-020-00260-w","article-title":"Metabolomic profiling of metoprolol hypertension treatment reveals altered gut microbiota-derived urinary metabolites","volume":"14","author":"Brocker","year":"2020","journal-title":"Hum. Genomics"},{"key":"B12","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1038\/s41586-024-07681-w","article-title":"In situ targeted base editing of bacteria in the mouse gut","volume":"632","author":"Br\u00f6del","year":"2024","journal-title":"Nature"},{"key":"B13","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.jare.2023.07.002","article-title":"Dissecting the human gut microbiome to better decipher drug liability: a once-forgotten organ takes center stage","volume":"52","author":"Cai","year":"2023","journal-title":"J. Adv. Res."},{"key":"B14","doi-asserted-by":"publisher","first-page":"103010","DOI":"10.1016\/j.redox.2023.103010","article-title":"Empagliflozin improves mitochondrial dysfunction in diabetic cardiomyopathy by modulating ketone body metabolism and oxidative stress","volume":"69","author":"Cai","year":"2024","journal-title":"Redox Biol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1016\/j.jacbts.2021.12.010","article-title":"Short-chain carbon sources: exploiting pleiotropic effects for heart failure therapy","volume":"7","author":"Challa","year":"2022","journal-title":"JACC Basic Transl. Sci."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1016\/j.jchf.2024.08.007","article-title":"Mineralocorticoid antagonism in heart failure: established and emerging therapeutic role","volume":"12","author":"Chang","year":"2024","journal-title":"JACC Heart Fail."},{"key":"B17","doi-asserted-by":"publisher","first-page":"742394","DOI":"10.3389\/fmed.2021.742394","article-title":"Pharmacomicrobiomics: exploiting the drug-microbiota interactions in antihypertensive treatment","volume":"8","author":"Chen","year":"2022","journal-title":"Front. Med."},{"key":"B18","doi-asserted-by":"publisher","first-page":"e125","DOI":"10.1002\/imt2.125","article-title":"Gut microbiota in heart failure and related interventions","volume":"2","author":"Chen A-T","year":"2023","journal-title":"Imeta"},{"key":"B19","doi-asserted-by":"publisher","first-page":"7249","DOI":"10.1038\/s41467-023-43167-5","article-title":"Gut butyrate-producers confer post-infarction cardiac protection","volume":"14","author":"Chen H-C","year":"2023","journal-title":"Nat. Commun."},{"key":"B20","doi-asserted-by":"publisher","first-page":"ii9","DOI":"10.1093\/eurjpc\/zwad166","article-title":"Fluid balance in heart failure","volume":"30","author":"Cosentino","year":"2023","journal-title":"Eur. J. Prev. Cardiol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1038\/s41569-020-0406-8","article-title":"SGLT2 inhibitors: mechanisms of cardiovascular benefit beyond glycaemic control","volume":"17","author":"Cowie","year":"2020","journal-title":"Nat. Rev. Cardiol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"489","DOI":"10.3949\/ccjm.91a.23105","article-title":"Digoxin is still useful, but is still causing toxicity","volume":"91","author":"Crane","year":"2024","journal-title":"Clevel. Clin. J. Med."},{"key":"B23","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.cmet.2019.10.005","article-title":"Microbial metabolite signaling is required for systemic iron homeostasis","volume":"31","author":"Das","year":"2020","journal-title":"Cell. Metab."},{"key":"B24","doi-asserted-by":"publisher","first-page":"175720","DOI":"10.1016\/j.ejphar.2023.175720","article-title":"Canagliflozin protects diabetic cardiomyopathy by mitigating fibrosis and preserving the myocardial integrity with improved mitochondrial function","volume":"949","author":"Dasari","year":"2023","journal-title":"Eur. J. Pharmacol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/s41575-023-00891-z","article-title":"Effects of dietary fibre on metabolic health and obesity","volume":"21","author":"Deehan","year":"2024","journal-title":"Nat. Rev. Gastroenterology and Hepatology"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1210\/clinem\/dgac210","article-title":"Cardiovascular benefits of empagliflozin are associated with gut microbiota and plasma metabolites in type 2 diabetes","volume":"107","author":"Deng","year":"2022","journal-title":"J. Clin. Endocrinol. Metabolism"},{"key":"B27","doi-asserted-by":"publisher","first-page":"153322","DOI":"10.1016\/j.phymed.2020.153322","article-title":"The cardiac protection of baoyuan decoction via gut-heart axis metabolic pathway","volume":"79","author":"Du","year":"2020","journal-title":"Phytomedicine Int. J. Phytotherapy Phytopharm."},{"key":"B28","doi-asserted-by":"publisher","first-page":"144","DOI":"10.3390\/nu13010144","article-title":"Role of gut microbiota and their metabolites on atherosclerosis, hypertension and human blood platelet function: a review","volume":"13","author":"Duttaroy","year":"2021","journal-title":"Nutrients"},{"key":"B29","doi-asserted-by":"publisher","first-page":"134223","DOI":"10.1016\/j.ijbiomac.2024.134223","article-title":"Polyphenols: chemistry, bioavailability, bioactivity, nutritional aspects and human health benefits: a review","volume":"277","author":"El-Saadony","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"141","DOI":"10.6133\/apjcn.202504_34(2).0001","article-title":"Diet and the gut microbiota profiles in individuals at risk of chronic heart failure\u2014A review on the Asian population","volume":"34","author":"Fadhillah","year":"2025","journal-title":"Asia Pac. J. Clin. Nutr."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1147687","DOI":"10.3389\/fcimb.2023.1147687","article-title":"Gut microbiota and cardiac arrhythmia","volume":"13","author":"Fan","year":"2023","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41569-022-00735-4","article-title":"The molecular and metabolic landscape of iron and ferroptosis in cardiovascular disease","volume":"20","author":"Fang","year":"2023","journal-title":"Nat. Rev. Cardiol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/s41392-024-01811-6","article-title":"Bile acid metabolism and signaling in health and disease: molecular mechanisms and therapeutic targets","volume":"9","author":"Fleishman","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"B34","doi-asserted-by":"publisher","first-page":"e1900752","DOI":"10.1002\/mnfr.201900752","article-title":"Interaction of gut microbiota and high-sodium, low-potassium diet in altering plasma triglyceride profiles revealed by lipidomics analysis","volume":"63","author":"Folz","year":"2019","journal-title":"Mol. Nutr. and Food Res."},{"key":"B35","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1038\/nature15766","article-title":"Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota","volume":"528","author":"Forslund","year":"2015","journal-title":"Nature"},{"key":"B36","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1038\/s41586-021-04177-9","article-title":"Combinatorial, additive and dose-dependent drug-microbiome associations","volume":"600","author":"Forslund","year":"2021","journal-title":"Nature"},{"key":"B37","doi-asserted-by":"publisher","first-page":"100387","DOI":"10.1016\/j.xkme.2021.09.004","article-title":"Deoxycholic acid and risks of cardiovascular events, ESKD, and mortality in CKD: the CRIC study","volume":"4","author":"Frazier","year":"2022","journal-title":"Kidney Med."},{"key":"B38","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1053\/j.gastro.2015.06.043","article-title":"Proton pump inhibitors alter specific taxa in the human gastrointestinal microbiome: a crossover trial","volume":"149","author":"Freedberg","year":"2015","journal-title":"Gastroenterology"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.1161\/CIRCRESAHA.123.322055","article-title":"Gut microbiota and microbial metabolism in early risk of cardiometabolic disease","volume":"132","author":"Gabriel","year":"2023","journal-title":"Circulation Res."},{"key":"B40","doi-asserted-by":"publisher","first-page":"106792","DOI":"10.1016\/j.jsbmb.2025.106792","article-title":"Microbial modulation of digoxin bioavailability: a pharmacomicrobiome perspective on Eggerthella Lenta\u2019s role in steroid-like drug metabolism and precision therapeutics","volume":"252","author":"Ganamurali","year":"2025","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"114149","DOI":"10.1016\/j.biopha.2022.114149","article-title":"Mineralocorticoid receptor blockade improved gut microbiota dysbiosis by reducing gut sympathetic tone in spontaneously hypertensive rats","volume":"158","author":"Gonz\u00e1lez-Correa","year":"2023","journal-title":"Biomed. and Pharmacother. = Biomedecine and Pharmacother."},{"key":"B42","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.1038\/s41440-023-01384-x","article-title":"Association between the gut microbiome and the renin-angiotensin-aldosterone system: a possible link via the activation of the immune system","volume":"46","author":"Gotoh","year":"2023","journal-title":"Hypertens. Res."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1002\/cpt.70066","article-title":"Pharmacomicrobiomics","volume":"118","author":"Gronich","year":"2025","journal-title":"Clin. Pharmacol. Ther."},{"key":"B44","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.amjmed.2024.08.018","article-title":"Expert consensus on the diagnosis and management of digoxin toxicity","volume":"138","author":"Hack","year":"2025","journal-title":"Am. J. Med."},{"key":"B45","doi-asserted-by":"publisher","first-page":"bbaa292","DOI":"10.1093\/bib\/bbaa292","article-title":"Drug response in association with pharmacogenomics and pharmacomicrobiomics: towards a better personalized medicine","volume":"22","author":"Hassan","year":"2021","journal-title":"Briefings Bioinforma."},{"key":"B46","doi-asserted-by":"publisher","first-page":"e263","DOI":"10.1016\/j.jacc.2021.12.012","article-title":"2022 AHA\/ACC\/HFSA guideline for the management of heart failure","volume":"79","author":"Heidenreich","year":"2022","journal-title":"J. Am. Coll. Cardiol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.jacbts.2019.11.007","article-title":"SGLT2 inhibitor-induced sympathoinhibition: a novel mechanism for cardiorenal protection","volume":"5","author":"Herat","year":"2020","journal-title":"JACC. Basic Transl. Sci."},{"key":"B48","doi-asserted-by":"publisher","first-page":"101706","DOI":"10.1016\/j.arr.2022.101706","article-title":"Short-chain fatty acid metabolism and multiple effects on cardiovascular diseases","volume":"81","author":"Hu","year":"2022","journal-title":"Ageing Res. Rev."},{"key":"B49","doi-asserted-by":"publisher","first-page":"2655","DOI":"10.1038\/s41467-018-05184-7","article-title":"Gut microbiota associations with common diseases and prescription medications in a population-based cohort","volume":"9","author":"Jackson","year":"2018","journal-title":"Nat. Commun."},{"key":"B50","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1016\/j.cell.2020.05.001","article-title":"Personalized mapping of drug metabolism by the human gut microbiome","volume":"181","author":"Javdan","year":"2020","journal-title":"Cell."},{"key":"B51","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s43705-022-00092-w","article-title":"MIxS-SA: a MIxS extension defining the minimum information standard for sequence data from symbiont-associated micro-organisms","volume":"2","author":"Jorge","year":"2022","journal-title":"ISME Commun."},{"key":"B52","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1053\/j.ajkd.2017.06.017","article-title":"Deoxycholic acid, a metabolite of circulating bile acids, and coronary artery vascular calcification in CKD","volume":"71","author":"Jovanovich","year":"2018","journal-title":"Am. J. Kidney Dis. Official J. Natl. Kidney Found."},{"key":"B53","doi-asserted-by":"publisher","first-page":"2539","DOI":"10.1007\/s11010-023-04683-6","article-title":"Probiotics as potential treatments to reduce myocardial remodelling and heart failure via the gut-heart axis: State-of-the-art review","volume":"478","author":"Karmazyn","year":"2023","journal-title":"Mol. Cell. Biochem."},{"key":"B54","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/j.jacc.2025.06.036","article-title":"Evidentiary landscape of heart failure therapies, regulatory decisions, and translation into guidelines","volume":"86","author":"Kaul","year":"2025","journal-title":"J. Am. Coll. Cardiol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1161\/CIRCULATIONAHA.119.043081","article-title":"Deficiency of prebiotic fiber and insufficient signaling through gut metabolite-sensing receptors leads to cardiovascular disease","volume":"141","author":"Kaye","year":"2020","journal-title":"Circulation"},{"key":"B56","doi-asserted-by":"publisher","first-page":"3770","DOI":"10.1172\/JCI94753","article-title":"Fibroblast-specific TGF-\u03b2-Smad2\/3 signaling underlies cardiac fibrosis","volume":"127","author":"Khalil","year":"2017","journal-title":"J. Clin. Investigation"},{"key":"B57","doi-asserted-by":"publisher","first-page":"e33953","DOI":"10.7554\/eLife.33953","article-title":"Discovery and characterization of a prevalent human gut bacterial enzyme sufficient for the inactivation of a family of plant toxins","volume":"7","author":"Koppel","year":"2018","journal-title":"Elife"},{"key":"B58","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1038\/s41586-025-09273-8","article-title":"Identification of medication\u2013microbiome interactions that affect gut infection","volume":"644","author":"Kumar","year":"2025","journal-title":"Nature"},{"key":"B59","doi-asserted-by":"publisher","first-page":"107672","DOI":"10.1016\/j.phrs.2025.107672","article-title":"Gut microbiota-derived metabolites: potential targets for cardiorenal syndrome","volume":"214","author":"Lai","year":"2025","journal-title":"Pharmacol. Res."},{"key":"B60","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/s41569-024-00988-1","article-title":"Iron deficiency and supplementation in heart failure","volume":"21","author":"Lakhal-Littleton","year":"2024","journal-title":"Nat. Rev. Cardiol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41574-025-01170-4","article-title":"Cardiometabolic and renal benefits of sodium\u2013glucose cotransporter 2 inhibitors","volume":"21","author":"Lee","year":"2025","journal-title":"Nat. Rev. Endocrinol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"106598","DOI":"10.1016\/j.nbd.2024.106598","article-title":"Sotagliflozin attenuates cardiac dysfunction and depression-like behaviors in mice with myocardial infarction through the gut-heart-brain axis","volume":"199","author":"Liao","year":"2024","journal-title":"Neurobiol. Dis."},{"key":"B63","doi-asserted-by":"publisher","first-page":"198","DOI":"10.3390\/jpm11030198","article-title":"Differences in the microbial composition of hemodialysis patients treated with and without \u03b2-blockers","volume":"11","author":"Lin","year":"2021","journal-title":"J. Personalized Med."},{"key":"B64","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1186\/s12933-022-01679-2","article-title":"Effect of pharmacological treatment on outcomes of heart failure with preserved ejection fraction: an updated systematic review and network meta-analysis of randomized controlled trials","volume":"21","author":"Lin","year":"2022","journal-title":"Cardiovasc. Diabetol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"3264","DOI":"10.1002\/ehf2.14915","article-title":"Global trends in heart failure from 1990 to 2019: an age-period-cohort analysis from the global burden of disease study","volume":"11","author":"Liu","year":"2024","journal-title":"Esc. Heart Fail."},{"key":"B66","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.3390\/nu13072402","article-title":"Vegan diet and the gut microbiota composition in healthy adults","volume":"13","author":"Losno","year":"2021","journal-title":"Nutrients"},{"key":"B67","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1007\/s11274-013-1507-x","article-title":"Intestinal microbiome and digoxin inactivation: meal plan for digoxin users?","volume":"30","author":"Lu","year":"2014","journal-title":"World J. Microbiol. Biotechnol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1161\/HYPERTENSIONAHA.122.20073","article-title":"Antihypertensives and antibiotics: impact on intestinal dysfunction and hypertension","volume":"80","author":"Lucas","year":"2023","journal-title":"Hypertension"},{"key":"B69","doi-asserted-by":"publisher","first-page":"4955","DOI":"10.3390\/ijms24054955","article-title":"Clostridium butyricum prevents dysbiosis and the rise in blood pressure in spontaneously hypertensive rats","volume":"24","author":"Luo","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"B70","doi-asserted-by":"publisher","first-page":"1321395","DOI":"10.3389\/fimmu.2024.1321395","article-title":"Role of the intestinal microbiome and its therapeutic intervention in cardiovascular disorder","volume":"15","author":"Luqman","year":"2024","journal-title":"Front. Immunol."},{"key":"B71","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1136\/heartjnl-2021-320054","article-title":"Trimethylamine oxide: a potential target for heart failure therapy","volume":"108","author":"Lv","year":"2022","journal-title":"Heart British Card. Soc."},{"key":"B72","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.1056\/NEJMra1600266","article-title":"The human intestinal microbiome in health and disease","volume":"375","author":"Lynch","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"B73","doi-asserted-by":"publisher","first-page":"3612","DOI":"10.1038\/s41467-024-47859-4","article-title":"Gut microbiome composition and metabolic activity in women with diverticulitis","volume":"15","author":"Ma","year":"2024","journal-title":"Nat. Commun."},{"key":"B74","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1038\/nature25979","article-title":"Extensive impact of non-antibiotic drugs on human gut bacteria","volume":"555","author":"Maier","year":"2018","journal-title":"Nature"},{"key":"B75","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.drudis.2021.11.005","article-title":"The role of DMPK science in improving pharmaceutical research and development efficiency","volume":"27","author":"Mak","year":"2022","journal-title":"Drug Discov. Today"},{"key":"B76","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.yjmcc.2020.12.001","article-title":"Gut microbiome - a potential mediator of pathogenesis in heart failure and its comorbidities: State-of-the-art review","volume":"152","author":"Mamic","year":"2021","journal-title":"J. Mol. Cell. Cardiol."},{"key":"B77","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1038\/s41598-018-37373-1","article-title":"Administration of N-acyl-phosphatidylethanolamine expressing bacteria to low density lipoprotein receptor-\/- mice improves indices of cardiometabolic disease","volume":"9","author":"May-Zhang","year":"2019","journal-title":"Sci. Rep."},{"key":"B78","doi-asserted-by":"publisher","first-page":"4901","DOI":"10.1093\/eurheartj\/ehab670","article-title":"Corrigendum to: 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: developed by the task force for the diagnosis and treatment of acute and chronic heart failure of the european society of cardiology (ESC) with the special contribution of the heart failure association (HFA) of the ESC","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur. Heart J."},{"key":"B79","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1038\/s41591-021-01552-x","article-title":"Reporting guidelines for human microbiome research: the STORMS checklist","volume":"27","author":"Mirzayi","year":"2021","journal-title":"Nat. Med."},{"key":"B80","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1002\/biof.1772","article-title":"Polyphenols as modulators of pre-established gut microbiota dysbiosis: State-of-the-art","volume":"48","author":"Molinari","year":"2022","journal-title":"BioFactors"},{"key":"B81","doi-asserted-by":"publisher","first-page":"F1032","DOI":"10.1152\/ajprenal.00051.2024","article-title":"Commensal microbiota regulate aldosterone","volume":"326","author":"Moore","year":"2024","journal-title":"Am. J. Physiology Ren. Physiology"},{"key":"B82","first-page":"190","article-title":"Effectiveness and safety of Sacubitril\/Valsartan in heart failure with preserved ejection fraction: a systematic review and meta-analysis","volume":"30","author":"Mou","year":"2024","journal-title":"Altern. Ther. Health Med."},{"key":"B83","doi-asserted-by":"publisher","first-page":"5227","DOI":"10.3390\/ijms25105227","article-title":"Differential modulation of catecholamine and adipokine secretion by the short chain fatty acid receptor FFAR3 and \u03b12-Adrenergic receptors in PC12 cells","volume":"25","author":"Nagliya","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"B84","unstructured":"NICOR\n          \n          \n          2025"},{"key":"B85","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1016\/S0140-6736(98)09286-1","article-title":"Endotoxin and immune activation in chronic heart failure: a prospective cohort study","volume":"353","author":"Niebauer","year":"1999","journal-title":"Lancet London, Engl."},{"key":"B86","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/s41581-022-00654-0","article-title":"The gut microbiome and hypertension","volume":"19","author":"O\u2019Donnell","year":"2023","journal-title":"Nat. Rev. Nephrol."},{"key":"B87","doi-asserted-by":"publisher","first-page":"H475","DOI":"10.1152\/ajpheart.00573.2020","article-title":"The role of diet-derived short-chain fatty acids in regulating cardiac pressure overload","volume":"320","author":"Pakhomov","year":"2021","journal-title":"Am. J. Physiology Heart Circulatory Physiology"},{"key":"B88","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s00248-022-02081-x","article-title":"Human gut microbiota and drug metabolism","volume":"86","author":"Pant","year":"2023","journal-title":"Microb. Ecol."},{"key":"B89","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.ejim.2021.03.035","article-title":"The use of \u03b2-blockers in patients with heart failure and comorbidities: doubts, certainties and unsolved issues","volume":"88","author":"Paolillo","year":"2021","journal-title":"Eur. J. Intern. Med."},{"key":"B90","doi-asserted-by":"publisher","first-page":"48","DOI":"10.4062\/biomolther.2021.078","article-title":"Novel GPR43 agonists exert an anti-inflammatory effect in a colitis model","volume":"30","author":"Park","year":"2022","journal-title":"Biomol. and Ther."},{"key":"B91","doi-asserted-by":"publisher","first-page":"103400","DOI":"10.1016\/j.etap.2020.103400","article-title":"Digoxin: pharmacology and toxicology-a review","volume":"79","author":"Patocka","year":"2020","journal-title":"Environ. Toxicol. Pharmacol."},{"key":"B92","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.chom.2024.03.001","article-title":"Opposing diet, microbiome, and metabolite mechanisms regulate inflammatory bowel disease in a genetically susceptible host","volume":"32","author":"Pereira","year":"2024","journal-title":"Cell. Host and Microbe"},{"key":"B93","doi-asserted-by":"publisher","first-page":"e0027322","DOI":"10.1128\/msystems.00273-22","article-title":"Menopause is associated with an altered gut microbiome and estrobolome, with implications for adverse cardiometabolic risk in the Hispanic community health study\/study of latinos","volume":"7","author":"Peters","year":"2022","journal-title":"mSystems"},{"key":"B94","doi-asserted-by":"publisher","first-page":"103338","DOI":"10.1016\/j.copbio.2025.103338","article-title":"Unveiling the prebiotic potential of polyphenols in gut health and metabolism","volume":"95","author":"Petersen","year":"2025","journal-title":"Curr. Opin. Biotechnol."},{"key":"B95","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1093\/eurheartj\/ehaa765","article-title":"Detection of patients at risk of developing heart failure responsive to mineralocorticoid receptor antagonists (MRAs): new insights and opportunities","volume":"42","author":"Pitt","year":"2021","journal-title":"Eur. Heart J."},{"key":"B96","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1161\/HYPERTENSIONAHA.124.23089","article-title":"Possible role of gut microbiota alterations in myocardial fibrosis and burden of heart failure in hypertensive heart disease","volume":"81","author":"Pitt","year":"2024","journal-title":"Hypertension"},{"key":"B97","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1038\/ismej.2016.117","article-title":"Absolute quantification of microbial taxon abundances","volume":"11","author":"Props","year":"2017","journal-title":"ISME J."},{"key":"B98","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.1080\/10408398.2019.1630599","article-title":"Mechanism and intervention measures of iron side effects on the intestine","volume":"60","author":"Qi","year":"2020","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"B99","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1038\/s44161-025-00637-x","article-title":"The gut microbiota-bile acid-TGR5 axis orchestrates platelet activation and atherothrombosis","volume":"4","author":"Qi","year":"2025","journal-title":"Nat. Cardiovasc. Res."},{"key":"B100","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1161\/CIRCULATIONAHA.118.034222","article-title":"Canagliflozin and heart failure in type 2 diabetes mellitus: results from the CANVAS program","volume":"138","author":"R\u00e5dholm","year":"2018","journal-title":"Circulation"},{"key":"B101","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1093\/ajh\/hpaa103","article-title":"Microbiota and hypertension: role of the sympathetic nervous system and the immune system","volume":"33","author":"Robles-Vera","year":"2020","journal-title":"Am. J. Hypertens."},{"key":"B102","doi-asserted-by":"publisher","first-page":"e009972","DOI":"10.1161\/CIRCHEARTFAILURE.122.009972","article-title":"Gut microbiota-generated phenylacetylglutamine and heart failure","volume":"16","author":"Romano","year":"2023","journal-title":"Circ. Heart Fail."},{"key":"B103","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1126\/science.6836275","article-title":"Digoxin-inactivating bacteria: identification in human gut flora","volume":"220","author":"Saha","year":"1983","journal-title":"Science"},{"key":"B104","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1016\/j.jacc.2007.07.016","article-title":"Altered intestinal function in patients with chronic heart failure","volume":"50","author":"Sandek","year":"2007","journal-title":"J. Am. Coll. Cardiol."},{"key":"B105","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1161\/CIRCRESAHA.116.309006","article-title":"Hypertension-linked pathophysiological alterations in the gut","volume":"120","author":"Santisteban","year":"2017","journal-title":"Circulation Res."},{"key":"B106","doi-asserted-by":"publisher","first-page":"3272","DOI":"10.1093\/cvr\/cvac013","article-title":"Global burden of heart failure: a comprehensive and updated review of epidemiology","volume":"118","author":"Savarese","year":"2023","journal-title":"Cardiovasc. Res."},{"key":"B107","doi-asserted-by":"publisher","first-page":"610","DOI":"10.34133\/research.0610","article-title":"Heart failure and gut microbiota: what is cause and effect?","volume":"8","author":"Shen","year":"2025","journal-title":"Research"},{"key":"B108","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1161\/CIRCRESAHA.125.325516","article-title":"Gut-heart axis: the role of gut microbiota and metabolites in heart failure","volume":"136","author":"Snelson","year":"2025","journal-title":"Circulation Res."},{"key":"B109","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1056\/NEJMoa1908655","article-title":"Angiotensin\u2013neprilysin inhibition in heart failure with preserved ejection fraction","volume":"381","author":"Solomon","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"B110","doi-asserted-by":"publisher","first-page":"100082","DOI":"10.1016\/j.pharmr.2025.100082","article-title":"Modern antidiabetic therapy by sodium-glucose cotransporter 2 inhibitors, glucagon-like peptide 1 receptor agonists, and dipeptidyl peptidase 4 inhibitors against cardiovascular diseases","volume":"77","author":"Steven","year":"2025","journal-title":"Pharmacol. Rev."},{"key":"B111","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1002\/ejhf.1338","article-title":"Association with outcomes and response to treatment of trimethylamine N-oxide in heart failure: results from BIOSTAT-CHF","volume":"21","author":"Suzuki","year":"2019","journal-title":"Eur. J. Heart Fail."},{"key":"B112","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1161\/CIRCRESAHA.117.309715","article-title":"Gut microbiota in cardiovascular health and disease","volume":"120","author":"Tang","year":"2017","journal-title":"Circulation Res."},{"key":"B113","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/s41569-018-0108-7","article-title":"Dietary metabolism, the gut microbiome, and heart failure","volume":"16","author":"Tang","year":"2019","journal-title":"Nat. Rev. Cardiol."},{"key":"B114","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1002\/ejhf.3111","article-title":"Prognostic value of gut microbe-generated metabolite phenylacetylglutamine in patients with heart failure","volume":"26","author":"Tang","year":"2024","journal-title":"Eur. J. Heart Fail."},{"key":"B115","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1056\/NEJMoa2025797","article-title":"Cardiac myosin activation with omecamtiv mecarbil in systolic heart failure","volume":"384","author":"Teerlink","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"B116","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s40168-018-0491-7","article-title":"Absolute quantitation of microbiota abundance in environmental samples","volume":"6","author":"Tkacz","year":"2018","journal-title":"Microbiome"},{"key":"B117","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1146\/annurev-pharmtox-022724-100847","article-title":"Pharma[e]cology: how the gut microbiome contributes to variations in drug response","volume":"65","author":"Trepka","year":"2025","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"B118","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.hjc.2022.04.006","article-title":"Real-world implementation of guidelines for heart failure management: a systematic review and meta-analysis","volume":"66","author":"Tsigkas","year":"2022","journal-title":"Hellenic J. Cardiol. HJC = Hellenike Kardiologike Epitheorese"},{"key":"B119","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1007\/s40262-021-01032-y","article-title":"Contribution of the gut microbiome to drug disposition, pharmacokinetic and pharmacodynamic variability","volume":"60","author":"Tsunoda","year":"2021","journal-title":"Clin. Pharmacokinet."},{"key":"B120","doi-asserted-by":"publisher","first-page":"e002314","DOI":"10.1161\/CIRCGEN.119.002314","article-title":"Gut microbiome and response to cardiovascular drugs","volume":"12","author":"Tuteja","year":"2019","journal-title":"Circulation Genomic Precis. Med."},{"key":"B121","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/S0140-6736(20)30748-0","article-title":"Estimating lifetime benefits of comprehensive disease-modifying pharmacological therapies in patients with heart failure with reduced ejection fraction: a comparative analysis of three randomised controlled trials","volume":"396","author":"Vaduganathan","year":"2020","journal-title":"Lancet"},{"key":"B122","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1038\/nature24460","article-title":"Quantitative microbiome profiling links gut community variation to microbial load","volume":"551","author":"Vandeputte","year":"2017","journal-title":"Nature"},{"key":"B123","doi-asserted-by":"publisher","first-page":"eadg8357","DOI":"10.1126\/scitranslmed.adg8357","article-title":"Integrating the gut microbiome and pharmacology","volume":"16","author":"Verdegaal","year":"2024","journal-title":"Sci. Transl. Med."},{"key":"B124","doi-asserted-by":"publisher","first-page":"e254","DOI":"10.1161\/CIR.0000000000000950","article-title":"Heart disease and stroke statistics-2021 update: a report from the American heart association","volume":"143","author":"Virani","year":"2021","journal-title":"Circulation"},{"key":"B125","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.jacc.2021.10.037","article-title":"Management of atrial fibrillation in patients 75 years and older: JACC state-of-the-art review","volume":"79","author":"Volgman","year":"2022","journal-title":"J. Am. Coll. Cardiol."},{"key":"B126","doi-asserted-by":"publisher","first-page":"254","DOI":"10.3390\/toxins16060254","article-title":"Indoxyl sulfate-induced macrophage toxicity and therapeutic strategies in uremic atherosclerosis","volume":"16","author":"Wakamatsu","year":"2024","journal-title":"Toxins"},{"key":"B127","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.2147\/JIR.S294630","article-title":"Restraint stress in hypertensive rats activates the intestinal macrophages and reduces intestinal barrier accompanied by intestinal flora dysbiosis","volume":"14","author":"Wang","year":"2021","journal-title":"J. Inflamm. Res."},{"key":"B128","doi-asserted-by":"publisher","first-page":"112156","DOI":"10.1016\/j.mce.2024.112156","article-title":"SGLT2 knockdown restores the Th17\/treg balance and suppresses diabetic nephropathy in db\/db mice by regulating SGK1 via Na","volume":"584","author":"Wang D","year":"2024","journal-title":"Mol. Cell. Endocrinol."},{"key":"B129","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1038\/s42255-024-01036-5","article-title":"Inhibition of fatty acid uptake by TGR5 prevents diabetic cardiomyopathy","volume":"6","author":"Wang H","year":"2024","journal-title":"Nat. Metab."},{"key":"B130","doi-asserted-by":"publisher","first-page":"13851","DOI":"10.1038\/s41598-024-64909-5","article-title":"Effect of dapagliflozin on ferroptosis through the gut microbiota metabolite TMAO during myocardial ischemia\u2013reperfusion injury in diabetes mellitus rats","volume":"14","author":"Wang L","year":"2024","journal-title":"Sci. Rep."},{"key":"B131","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1136\/gutjnl-2019-320204","article-title":"Interaction between drugs and the gut microbiome","volume":"69","author":"Weersma","year":"2020","journal-title":"Gut"},{"key":"B132","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1007\/s10620-020-06112-w","article-title":"Diet and the human gut microbiome: an international review","volume":"65","author":"Wilson","year":"2020","journal-title":"Dig. Dis. Sci."},{"key":"B133","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1161\/CIRCRESAHA.120.316242","article-title":"Gut microbiota and cardiovascular disease","volume":"127","author":"Witkowski","year":"2020","journal-title":"Circulation Res."},{"key":"B134","doi-asserted-by":"publisher","first-page":"1331609","DOI":"10.3389\/fimmu.2024.1331609","article-title":"Role of Treg cell subsets in cardiovascular disease pathogenesis and potential therapeutic targets","volume":"15","author":"Xia","year":"2024","journal-title":"Front. Immunol."},{"key":"B135","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1038\/s41392-020-00411-4","article-title":"Ketogenic diets inhibit mitochondrial biogenesis and induce cardiac fibrosis","volume":"6","author":"Xu","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"B136","doi-asserted-by":"publisher","first-page":"2718","DOI":"10.2337\/dc22-0323","article-title":"SGLT2 inhibition, choline metabolites, and cardiometabolic diseases: a mediation mendelian randomization study","volume":"45","author":"Xu","year":"2022","journal-title":"Diabetes Care"},{"key":"B137","doi-asserted-by":"publisher","first-page":"fiab043","DOI":"10.1093\/femsec\/fiab043","article-title":"Gut bacteria formation and influencing factors","volume":"97","author":"Yang","year":"2021","journal-title":"FEMS Microbiol. Ecol."},{"key":"B138","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1161\/HYPERTENSIONAHA.121.18711","article-title":"Identification of a gut commensal that compromises the blood pressure-lowering effect of ester angiotensin-converting enzyme inhibitors","volume":"79","author":"Yang","year":"2022","journal-title":"Hypertens. (Dallas, Tex. 1979)"},{"key":"B139","doi-asserted-by":"publisher","first-page":"2263210","DOI":"10.1080\/19490976.2023.2263210","article-title":"The influence of microbiota on ferroptosis in intestinal diseases","volume":"15","author":"Yao","year":"2023","journal-title":"Gut Microbes"},{"key":"B140","doi-asserted-by":"publisher","first-page":"e14365","DOI":"10.1111\/1751-7915.14365","article-title":"Dengzhanshengmai capsule alleviates heart failure and concomitantly decreases phenylacetylglutamine level, interacting with the intestinal microflora in rats","volume":"17","author":"Yi","year":"2024","journal-title":"Microb. Biotechnol."},{"key":"B141","doi-asserted-by":"publisher","first-page":"114430","DOI":"10.1016\/j.bcp.2021.114430","article-title":"Intestine-specific FXR agonists as potential therapeutic agents for colorectal cancer","volume":"186","author":"Yin","year":"2021","journal-title":"Biochem. Pharmacol."},{"key":"B142","doi-asserted-by":"publisher","first-page":"105639","DOI":"10.1016\/j.archger.2024.105639","article-title":"Impact of gut microbiota on cardiac aging","volume":"128","author":"Yin","year":"2025","journal-title":"Archives Gerontology Geriatrics"},{"key":"B143","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.ijcard.2017.11.071","article-title":"A potential relationship between gut microbes and atrial fibrillation: Trimethylamine N-oxide, a gut microbe-derived metabolite, facilitates the progression of atrial fibrillation","volume":"255","author":"Yu","year":"2018","journal-title":"Int. J. Cardiol."},{"key":"B144","doi-asserted-by":"publisher","first-page":"118091","DOI":"10.1016\/j.jep.2024.118091","article-title":"Mechanism of tianma-gouteng granules lowering blood pressure based on the bile acid-regulated farnesoid X receptor-fibroblast growth factor 15- cholesterol 7\u03b1-hydroxylase pathway","volume":"328","author":"Yu","year":"2024","journal-title":"J. Ethnopharmacol."},{"key":"B145","doi-asserted-by":"publisher","first-page":"107864","DOI":"10.1016\/j.phrs.2025.107864","article-title":"Intermittent fasting ameliorates resistant hypertension through modulation of gut microbiota","volume":"219","author":"Yun","year":"2025","journal-title":"Pharmacol. Res."},{"key":"B146","doi-asserted-by":"publisher","first-page":"6242","DOI":"10.1039\/c7ra13729j","article-title":"3-(4-Hydroxyphenyl)propionic acid, a major microbial metabolite of procyanidin A2, shows similar suppression of macrophage foam cell formation as its parent molecule","volume":"8","author":"Zhang","year":"2018","journal-title":"RSC Adv."},{"key":"B147","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1016\/j.apsb.2020.09.013","article-title":"The influence of the gut microbiota on the bioavailability of oral drugs","volume":"11","author":"Zhang X","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"B148","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.trsl.2020.08.007","article-title":"TMAO: how gut microbiota contributes to heart failure","volume":"228","author":"Zhang Y","year":"2021","journal-title":"Transl. Res."},{"key":"B149","doi-asserted-by":"publisher","first-page":"116567","DOI":"10.1016\/j.biopha.2024.116567","article-title":"Role of the microbiota\u2013gut\u2013heart axis between bile acids and cardiovascular disease","volume":"174","author":"Zhang","year":"2024","journal-title":"Biomed. and Pharmacother."},{"key":"B150","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.chom.2025.08.014","article-title":"Gut-microbiota-derived indole sulfate promotes heart failure in chronic kidney disease","author":"Zhang","year":"2025","journal-title":"Cell. Host and Microbe"},{"key":"B151","doi-asserted-by":"publisher","first-page":"2505119","DOI":"10.1080\/19490976.2025.2505119","article-title":"Faecalibacterium prausnitzii prevents age-related heart failure by suppressing ferroptosis in cardiomyocytes through butyrate-mediated LCN2 regulation","volume":"17","author":"Zhang","year":"2025","journal-title":"Gut Microbes"},{"key":"B152","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1038\/s41392-023-01619-w","article-title":"Drug-microbiota interactions: an emerging priority for precision medicine","volume":"8","author":"Zhao","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"B153","doi-asserted-by":"publisher","first-page":"118182","DOI":"10.1016\/j.biopha.2025.118182","article-title":"The bile acid-gut microbiota axis: a central hub for physiological regulation and a novel therapeutic target for metabolic diseases","volume":"188","author":"Zhao M","year":"2025","journal-title":"Biomed. and Pharmacother."},{"key":"B154","doi-asserted-by":"publisher","first-page":"101592","DOI":"10.1016\/j.gendis.2025.101592","article-title":"Decoding the impact of gut microbiota on heart failure","volume":"12","author":"Zhao S","year":"2025","journal-title":"Genes. and Dis."},{"key":"B155","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1136\/gutjnl-2023-330168","article-title":"Compared to histamine-2 receptor antagonist, proton pump inhibitor induces stronger oral-to-gut microbial transmission and gut microbiome alterations: a randomised controlled trial","volume":"73","author":"Zhu","year":"2024","journal-title":"Gut"},{"key":"B156","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.apsb.2016.04.004","article-title":"PBPK modeling and simulation in drug research and development","volume":"6","author":"Zhuang","year":"2016","journal-title":"Acta Pharm. Sin. B"},{"key":"B157","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1111\/obr.12843","article-title":"Gut microbe-generated metabolite trimethylamine N-oxide and the risk of diabetes: a systematic review and dose-response meta-analysis","volume":"20","author":"Zhuang","year":"2019","journal-title":"Obes. Rev. Official J. Int. Assoc. Study Obes."},{"key":"B158","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1038\/s41586-019-1291-3","article-title":"Mapping human microbiome drug metabolism by gut bacteria and their genes","volume":"570","author":"Zimmermann","year":"2019","journal-title":"Nature"},{"key":"B159","doi-asserted-by":"publisher","first-page":"2645","DOI":"10.1002\/ehf2.13989","article-title":"Phenylacetylglutamine as a risk factor and prognostic indicator of heart failure","volume":"9","author":"Zong","year":"2022","journal-title":"Esc. Heart Fail."},{"key":"B160","doi-asserted-by":"publisher","first-page":"4219","DOI":"10.7150\/ijbs.70644","article-title":"Commensal microbe-derived SCFA alleviates atrial fibrillation via GPR43\/NLRP3 signaling","volume":"18","author":"Zuo","year":"2022","journal-title":"Int. J. Biol. Sci."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1781470\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T05:42:31Z","timestamp":1776231751000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1781470\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,15]]},"references-count":160,"alternative-id":["10.3389\/fphar.2026.1781470"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2026.1781470","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,15]]},"article-number":"1781470"}}